Abstract
Donation-related data for 1488 allogeneic peripheral blood stem cell (PBSC) transplants reported to the International Bone Marrow Transplant Registry (IBMTR) or the European Blood and Marrow Transplant Group (EBMT) by 152 teams worldwide between 1994 and 1998 were reviewed. In 1998, 26% of allografts registered with the IBMTR were collected from blood. Median age of PBSC donors was 38 years (range <1–76), and 55% were male. Of 1486 donor–recipient pairs evaluable for HLA compatibility, 1322 (89%) were HLA-identical siblings. Recombinant human granulocyte colony-stimulating factor (G-CSF) was employed to mobilize PBSCs in almost all (99%) cases. One hundred and seventy (20%) of 828 evaluable PBSC donors had a central catheter placed for leukapheresis. Eighty-five percent of 1321 evaluable PBSC grafts were collected with one or two leukaphereses. There were 15 reported donation-related adverse events (1% of evaluable donors). Complications were catheter-related in five. No donation-related fatalities were reported. These data suggest that PBSC donation is becoming more prevalent worldwide. It appears to have a safety profile comparable to marrow harvesting, although experience with the latter is much more extensive. Bone Marrow Transplantation (2001) 27, 689–692.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Goldman J . Peripheral blood stem cells for allografting Blood 1995 85: 1413–1415
Russell N, Gratwohl A, Schmitz N . The place of blood stem cells in allogeneic transplantation Br J Haematol 1996 93: 747–753
Lane TA . Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era Transfusion 1996 36: 585–589
Bishop MR, Tarantolo SR, Jackson JD et al. Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor J Clin Oncol 1997 15: 1601–1607
Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation Blood 1996 88: 2794–2800
Brown RA, Adkins D, Goodnough LT et al. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies J Clin Oncol 1997 15: 3067–3074
Martinez C, Urbano-Ispizua A, Rozman C et al. Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors Ann Hematol 1996 72: 269–272
Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft Br J Haematol 1994 87: 609–613
Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors Bone Marrow Transplant 1995 15: 111–115
Stroncek DF, Clay ME, Petzoldt ML et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells Transfusion 1996 36: 601–610
Buckner CD, Clift RA, Sanders JE et al. Marrow harvesting from normal donors Blood 1984 64: 630–634
Bortin MM, Buckner CD . Major complications of marrow harvesting for transplantation Exp Hematol 1983 11: 916–921
Stroncek DF, Holland PV, Bartch G et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program Blood 1993 81: 1940–1946
Anderlini P, Körbling M, Dale D et al. Allogeneic blood stem cell transplantation: considerations for donors Blood 1997 90: 903–908
Anderlini P, Donato M, Chan KW et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the MD Anderson Cancer Center experience Transfusion 1999 39: 555–560
Majolino I, Cavallaro AM, Bacigalupo A et al. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO) Haematologica 1997 82: 47–52
Luider J, Brown C, Selinger S et al. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis J Hematother 1997 6: 575–580
Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte–macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation Blood 1995 85: 275–282
Vij R, Brown RA, Adkins D et al. Mobilization of normal donors with G-CSF + GM-CSF is associated with improved yield of hematopoietic progenitors and increased numbers of activated dendritic cells (abstract) Blood 1998 92: 682a
Parkkali T, Volin L, Siren MK et al. Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor Bone Marrow Transplant 1996 17: 433–434
Becker PS, Wagle M, Matous S et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells Biol Blood Marrow Transplant 1997 3: 45–49
Acknowledgements
Supported by Public Health Service Grants P01-CA-40053 and U24-CA76518 from the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and the National Heart, Lung and Blood Institute, of the US Department of Health and Human Services; and grants from Amgen, Inc.; Anonymous; Baxter Fenwal; Berlex Laboratories; Blue Cross and Blue Shield Association; Lynde and Harry Bradley Foundation; Bristol-Myers Squibb Oncology; Cell Therapeutics; Center for Advanced Studies in Leukemia; Chimeric Therapies; Chiron Therapeutics; COBE BCT Inc.; Eleanor Naylor Dana Charitable Trust; Deborah J Dearholt Memorial Fund; Empire Blue Cross Blue Shield; Eppley Foundation for Research; Fromstein Foundation; Fujisawa Healthcare, Inc.; Genentech, Inc.; Hoechst Marion Roussel; Horizon Medical Products; Human Genome Sciences; IDEC Pharmaceuticals; Immunex Corporation; IMPATH/BIS; IntraBiotics Pharmaceuticals; Kaiser Permanente; Kettering Family Foundation; Kirin Brewery Company; Robert J Kleberg, Jr and Helen C Kleberg Foundation; Herbert H Kohl Charities; Life Trac/Allianz; The Liposome Company; Nada and Herbert P Mahler Charities; Market Certitude; Mayer Ventures; MDS Nordian; MedImmune, Inc.; Milliman & Robertson, Inc.; Milstein Family Foundation; Miltenyi Biotech; Milwaukee Foundation/ Elsa Schoeneich Research Fund; Mutual of Omaha; Nexell Therapeutics; NeXstar Pharmaceuticals, Inc; Samuel Roberts Noble Foundation; Novartis Pharmaceuticals; Orphan Medical; Ortho Biotech, Inc.; John Oster Family Foundation; Jane and Lloyd Pettit Foundation; Pfizer, Inc.; Pharmacia and Upjohn; Principal Life Insurance Company; Protide Pharmaceuticals; RGK Foundation; Rhône-Poulenc Rorer Pharmaceuticals, Inc.; Roche Laboratories; SangStat Medical Corporation; Schering AG; Schering-Plough Oncology; Searle; SmithKline Beecham Pharmaceutical; Stackner Family Foundation; The Starr Foundation; StemCell Technologies; SyStemix; Therakos; TheraTechnologies; United Resource Networks; US Oncology; and Wyeth-Ayerst Laboratories.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anderlini, P., Rizzo, J., Nugent, M. et al. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 27, 689–692 (2001). https://doi.org/10.1038/sj.bmt.1702875
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702875
Keywords
This article is cited by
-
Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation
Bone Marrow Transplantation (2023)
-
Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study
Drugs - Real World Outcomes (2022)
-
Sixty as the new forty: considerations on older related stem cell donors
Bone Marrow Transplantation (2017)
-
A review of the haematopoietic stem cell donation experience: is there room for improvement?
Bone Marrow Transplantation (2014)
-
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts
Bone Marrow Transplantation (2014)